StockNews.AI
GOCO
StockNews.AI
98 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO

1. Pomerantz LLP investigates potential securities fraud claims against GoHealth. 2. DOJ filed a complaint alleging GoHealth received illegal kickbacks since 2016. 3. GoHealth's stock dropped 10.35% following DOJ's announcement on May 1, 2025. 4. Investors are urged to join the class action lawsuit. 5. Potential legal issues may affect investor confidence in GoHealth.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The stock's 10.35% drop indicates severe investor concern, potentially leading to continued sell-off. Historical precedents show similar legal issues can depress stock prices significantly.

How important is it?

High likelihood of impact due to the serious nature of the allegations and investor response.

Why Long Term?

Ongoing legal investigations can have prolonged effects on stock performance, as seen in similar past cases. Recovery often takes time pending legal resolutions.

Related Companies

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including GoHealth, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.”  On news of the DOJ’s lawsuit, GoHealth’s stock price fell $1.09 per share, or 10.35%, to close at $9.44 per share on May 1, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News